文献速递乳腺外科

局部治疗与年轻乳腺癌患者生活质量结局的关联

Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer.
PubMed 文献 · JAMA Surg · 2021-10-13

该多中心横断面研究纳入560例≤40岁乳腺癌患者,中位诊断后5.8年完成BREAST-Q调查,52%接受双侧乳房切除术。多因素分析显示假体再造较自体重建乳房满意度更低,复杂再造较自体重建躯体健康更差。局部治疗与多个生活质量领域较差评分持续相关,尤其乳房切除和放疗者。

要点

  • 年轻乳腺癌幸存者中双侧乳房切除术占52%,局部治疗与多个生活质量领域较差评分相关。
  • 假体再造较自体重建乳房满意度更低(β=-7.4,95%CI -12.8至-2.1,P=.007)。
  • 复杂再造较自体重建躯体健康更差(β=-14.0,95%CI -22.2至-5.7,P<.001)。

核心结论

  • 年轻乳腺癌幸存者的局部治疗与多个生活质量领域较差评分持续相关,尤其乳房切除和放疗者,无论是否再造。
  • 社会经济压力因素似乎也起作用。

研究设计与样本

  • 多中心横断面研究,前瞻性队列,2016年10月至2017年11月在北美学术和社区医院开展。
  • 纳入Young Women's Breast Cancer Study中≤40岁女性,共560例0–III期乳腺癌患者,中位诊断年龄36岁(范围17–40岁),484例(86%)为0–II期。
  • 中位诊断后5.8年(范围1.9–10.4年)完成BREAST-Q调查。

主要发现

  • 290例(52%)接受双侧乳房切除术,110例(20%)单侧乳房切除术,160例(28%)保乳治疗。
  • 乳房切除患者中357例(89%)接受再造,181例(45%)接受放疗。
  • 多因素分析中,假体再造较自体重建与乳房满意度降低相关(β=-7.4;95%CI -12.8至-2.1;P=.007)。
  • 复杂再造较自体重建与躯体健康更差相关(β=-14.0;95%CI -22.2至-5.7;P<.001)。

临床怎么用

  • 年轻乳腺癌患者选择局部治疗方式时,应将长期生活质量和再造方式对满意度及躯体健康的影响纳入共同决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Increasing rates of bilateral mastectomy have been most pronounced in young women with breast cancer, but the association of surgery with long-term quality of life (QOL) remains largely unknown. OBJECTIVE: To examine the association of surgery with longer-term satisfaction and QOL in young breast cancer survivors. DESIGN, SETTING, AND PARTICIPANTS: This multicenter cross-sectional study of a prospective cohort was conducted from October 2016 to November 2017, at academic and community hospitals in North America. Women 40 years or younger enrolled in the Young Women's Breast Cancer Study were assessed. Data analysis was performed from during a 1- to 2-year period after conclusion of the study. EXPOSURES: Primary breast surgery, reconstruction, and radiotherapy. MAIN OUTCOMES AND MEASURES: Mean BREAST-Q breast satisfaction and physical, psychosocial, and sexual well-being scores were compared by type of surgery; higher BREAST-Q scores (range, 0-100) indicate better QOL. Linear regression was used to identify demographic and clinical factors associated with BREAST-Q scores for each domain. RESULTS: A total of 560 women with stage 0 to III breast cancer (median age at diagnosis, 36 years; range, 17-40 years; 484 [86%] with stage 0-II disease) completed the BREAST-Q a median of 5.8 years (range, 1.9-10.4 years) from diagnosis. A total of 290 patients (52%) of patients underwent bilateral mastectomy, 110 patients (20%) underwent unilateral mastectomy, and 160 patients (28%) received breast-conserving therapy. Among mastectomy patients, 357 (89%) had reconstruction and 181 (45%) received radiotherapy. In multivariate analyses, implant-based reconstruction (vs autologous) was associated with decreased breast satisfaction (β = -7.4; 95% CI, -12.8 to -2.1; P = .007) and complex reconstruction (vs autologous) with worse physical well-being (β = -14.0; 95% CI, -22.2 to -5.7; P < .001). CONCLUSIONS AND RELEVANCE: These results suggest that local therapy in young breast cancer survivors is persistently associated with poorer scores in multiple QOL domains, particularly among those treated with mastectomy and radiotherapy, irrespective of breast reconstruction. Socioeconomic stressors also appear to play a role.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Dominici L, Hu J, Zheng Y, et al. Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer. JAMA Surg. 2021. PMID: 34468718. doi:10.1001/jamasurg.2021.3758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。